Send the following on WhatsApp
Continue to ChatFDA 核准 olaparib 用於 HRR 相關變異的轉移性荷爾蒙抗性前列腺癌 https://geneonline.news/fda-approves-olaparib-for-mcrpc/?variant=zh-cn
FDA 核准 olaparib 用於 HRR 相關變異的轉移性荷爾蒙抗性前列腺癌 https://geneonline.news/fda-approves-olaparib-for-mcrpc/?variant=zh-cn